Editorial
 FDC ISSUE IN SUPREME COURT   
 Wednesday, November 15, 2017 
 The Centre’s decision to withdraw irrational and harmful combination drugs from the market continues to be entangled in courts with no early solution in sight. 
  Past Editorial...  
TODAY'S NEWS
13:00  [IST]EMA grants marketing approval for once-daily single inhaler triple therapy Trelegy Ellipta to treat COPD
12:30  [IST]Wellthy Therapeutics conducts first made-in-India ‘digital pill’ clinical trial for diabetes
12:00  [IST]US FDA approves Chugai’s Hemlibra to treat haemophilia A with inhibitors
11:00  [IST]Grünenthal receives €2 million grant from European fund for regional development and state of North Rhine-Westphalia
10:00  [IST]US FDA approves Pfizer's Sutent to treat adult patients at high risk of recurrent RCC
09:00  [IST]Roche to buy California-based software company Viewics, Inc
more news >>
TOP NEWS
08:00  [IST]Maha govt, Centre to join hands for developing APIs, device parks at MIHAN, Nagpur
08:00  [IST]Health ministry introduces daily drug regimen for treatment of tuberculosis
08:00  [IST]Life sciences sector heralds new age in digital health with artificial intelligence & data science: Kiran Mazumdar-Shaw
08:00  [IST]AVPS Chakravarthi emerges as first Asian to be honoured as Global Ambassador for WPO
08:00  [IST]UK healthcare cos discuss collaborations with Indian healthcare institutions to further cancer care
08:00  [IST]FERCAP & FERCI conference to deliberate on “Strengthening international research collaboration through good ethical practices”
more news >>
YESTERDAY'S NEWS
17:50  [IST]Counselling for mothers on nutrition and care improves pre-term babies’ health: Abbott survey
17:45  [IST]By 2030 non-communicable diseases will be 75% of total disease burden: Health experts
17:20  [IST]Karnataka’s Private Hospitals and Nursing Homes Association withdraw strike, protests to continue in Belagavi
17:15  [IST]SBI opens Child Dialysis Centre and donates advanced equipment to St. John’s Medical Hospital
16:50  [IST]Max Bupa introduces ‘AnyTimeHealth’ machines to allow non-invasive health assessment
15:10  [IST]Cipla receives US FDA approval to market generic Pulmicort Respules
more news >>
INTERVIEW  
India has miles to go for accessing safe blood
Dr Shravan Subramanyam, managing director, Roche Diagnostics India
Past Interviews...
 
  What's New?  
 
Opinion Poll
 
 
Is the Delhi High Court's order to bar lab technicians from certifying medical test reports justifiable?
 
 
 
 

   
 
 
  Corporate
Pharma Stocks
Executive Diary
Pharma People
Product Launches
  Special Features
Features
  Chronicle Pharmabiz Specials
Forthcoming
  Past
 
  Forthcoming Events
International
  Domestic
 
TENDERS & PROJECTS
Tenders & Enquiries
Pharma Projects
CORPORATE
Company Profile
Corporate Results
Corporate X-ray
Pharmabiz Studies of Top Companies
US FDA UPDATE
US FDA: ANDA
US FDA: Warnings
US FDA: Approved NMEs
US FDA: New Approvals
US FDA: REFUSAL
EXPORT & IMPORT
Drug Export Procedures
Drug Units With WHO GMP Certification
Pharma Export Data
Import Reg. Update
PHARMA LAWS & DOCUMENTS
Notifications
Pharma Regulations
Patent Laws and Amendments
Patent Scan
Documents
New Drug Approvals
Notified Prices
LIST OF LABS & GOVT. BODIES
Govt Recognised In-House R&D Units
AICTE Boards & Committees
List of Indian CROs
List of CROs (International)
Govt & approved labs of India
List of State Drugs Controllers
 
 
PITS_2017
Pre-Connect Congress 2017
acssymposium
PHARMACONNECT_2018
 
 
 
 
Copyright © 2016 Saffron Media Pvt. Ltd |